Munehisa Shimamura

3.4k total citations
97 papers, 2.6k citations indexed

About

Munehisa Shimamura is a scholar working on Molecular Biology, Surgery and Neurology. According to data from OpenAlex, Munehisa Shimamura has authored 97 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 23 papers in Surgery and 19 papers in Neurology. Recurrent topics in Munehisa Shimamura's work include Neuroinflammation and Neurodegeneration Mechanisms (16 papers), Bone Metabolism and Diseases (9 papers) and Lipoproteins and Cardiovascular Health (7 papers). Munehisa Shimamura is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (16 papers), Bone Metabolism and Diseases (9 papers) and Lipoproteins and Cardiovascular Health (7 papers). Munehisa Shimamura collaborates with scholars based in Japan, France and United States. Munehisa Shimamura's co-authors include Ryuichi Morishita, Hironori Nakagami, Hitomi Kurinami, Hiromi Rakugi, Hiroshi Koriyama, Naoyuki Sato, Kouji Wakayama, Mariana Kiomy Osako, Toshio Ogihara and Hideo Shimizu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Munehisa Shimamura

96 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Munehisa Shimamura Japan 31 957 495 437 345 333 97 2.6k
Hulun Li China 35 1.1k 1.2× 953 1.9× 468 1.1× 301 0.9× 274 0.8× 125 3.4k
Shannon E. Dunn Canada 24 1.2k 1.2× 1.1k 2.3× 252 0.6× 428 1.2× 316 0.9× 55 3.1k
Robert Moumdjian Canada 29 784 0.8× 443 0.9× 523 1.2× 160 0.5× 470 1.4× 65 3.0k
Shintaro Nakao Japan 41 2.0k 2.1× 892 1.8× 566 1.3× 245 0.7× 270 0.8× 214 5.5k
Hai-dong Guo China 25 1.3k 1.4× 293 0.6× 367 0.8× 360 1.0× 314 0.9× 61 2.6k
Kees Fluiter Netherlands 30 1.6k 1.7× 334 0.7× 246 0.6× 214 0.6× 339 1.0× 53 2.7k
Tsunehiko Ikeda Japan 31 1.0k 1.1× 180 0.4× 325 0.7× 287 0.8× 219 0.7× 247 3.5k
Hyun Ah Kim South Korea 30 866 0.9× 547 1.1× 724 1.7× 217 0.6× 167 0.5× 82 2.5k
Hideto Yonekura Japan 36 1.3k 1.4× 490 1.0× 387 0.9× 487 1.4× 206 0.6× 83 4.8k
Zhongyang Lu United States 25 897 0.9× 314 0.6× 267 0.6× 226 0.7× 515 1.5× 58 2.6k

Countries citing papers authored by Munehisa Shimamura

Since Specialization
Citations

This map shows the geographic impact of Munehisa Shimamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munehisa Shimamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munehisa Shimamura more than expected).

Fields of papers citing papers by Munehisa Shimamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munehisa Shimamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munehisa Shimamura. The network helps show where Munehisa Shimamura may publish in the future.

Co-authorship network of co-authors of Munehisa Shimamura

This figure shows the co-authorship network connecting the top 25 collaborators of Munehisa Shimamura. A scholar is included among the top collaborators of Munehisa Shimamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munehisa Shimamura. Munehisa Shimamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimamura, Munehisa, Yuki Etani, Takaaki Noguchi, et al.. (2025). Receptor activator of nuclear factor-kappa B ligand-derived microglia healing peptide 1-AcN inhibits osteoarthritis progression in mice. Arthritis Research & Therapy. 27(1). 142–142. 1 indexed citations
2.
Yoshida, Shota, Hiroki Hayashi, Shunsuke Katsuki, et al.. (2024). A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts. Circulation Research. 136(1). 26–40. 5 indexed citations
3.
Kawano, Tomohiro, et al.. (2023). Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke. Journal of the American Heart Association. 12(6). e028125–e028125. 7 indexed citations
4.
Shimamura, Munehisa, Hiroki Hayashi, Shota Yoshida, et al.. (2023). R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice. Stroke. 54(6). 1606–1615. 2 indexed citations
5.
Hayashi, Hiroki, Jiao Sun, Tomoyuki Nishikawa, et al.. (2023). Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction. Scientific Reports. 13(1). 13033–13033. 3 indexed citations
6.
Takeda, Shuko, T. Nakajima, Yoichi Takami, et al.. (2023). Antiepileptic Drugs Modulate Alzheimer-Related Tau Aggregation in a Neuronal Activity-Independent Manner. Dementia and Geriatric Cognitive Disorders. 52(2). 108–116. 4 indexed citations
7.
Biagi, Carlos Alberto Oliveira de, Kamila Chagas Peronni, Hiroki Hayashi, et al.. (2022). RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages. BioMed Research International. 2022(1). 7740079–7740079. 13 indexed citations
8.
Kawano, Tomohiro, Tsutomu Sasaki, Yasufumi Gon, et al.. (2021). High neutrophil/lymphocyte ratio at cancer diagnosis predicts incidence of stroke in cancer patients. Brain Communications. 3(2). fcab071–fcab071. 7 indexed citations
9.
Yoshida, Shota, Hironori Nakagami, Hiroki Hayashi, et al.. (2020). The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature Communications. 11(1). 2482–2482. 106 indexed citations
10.
Baba, Kousuke, Tatsusada Okuno, Makoto Kinoshita, et al.. (2020). Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System. Neurotherapeutics. 18(1). 460–473. 9 indexed citations
11.
Shimamura, Munehisa, Hiroki Hayashi, Yuka Ikeda, et al.. (2019). Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis. Scientific Reports. 9(1). 15434–15434. 15 indexed citations
12.
Kawano, Tomohiro, Munehisa Shimamura, Hironori Nakagami, et al.. (2019). Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice. PLoS ONE. 14(5). e0215482–e0215482. 11 indexed citations
13.
Minhas, Gillipsie, et al.. (2015). Modeling transient retinal ischemia in mouse by ligation of pterygopalatine artery. Annals of Neurosciences. 22(4). 8 indexed citations
14.
Nakagami, Hironori, Hiroshi Koriyama, H. Tomioka, et al.. (2013). Development of novel DNA vaccine for VEGF in murine cancer model. Scientific Reports. 3(1). 3380–3380. 15 indexed citations
15.
Nakagami, Futoshi, Hiroshi Koriyama, Hironori Nakagami, et al.. (2013). Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice. PLoS ONE. 8(3). e60493–e60493. 38 indexed citations
16.
Sato, Naoyuki, Hitomi Kurinami, Daisuke Takeuchi, et al.. (2010). Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance. Journal of Biological Chemistry. 285(29). 22091–22102. 99 indexed citations
17.
Kunz, Alexander, T Abe, Karin Hochrainer, et al.. (2008). Nuclear Factor-κB Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery Occlusion. Journal of Neuroscience. 28(7). 1649–1658. 98 indexed citations
18.
Shimamura, Munehisa. (2006). HVJ-based non-viral gene transfer method: successful gene therapy using HGF and VEGF genes in experimental ischemia. Frontiers in bioscience. 11(1). 753–753. 12 indexed citations
19.
Sato, Naoyuki, Masayasu Okochi, Yoshiaki Taniyama, et al.. (2006). Development of new screening system for Alzheimer disease, in vitro Aβ sink assay, to identify the dissociation of soluble Aβ from fibrils. Neurobiology of Disease. 22(3). 487–495. 6 indexed citations
20.
Koike, Hiromi, Akihiko Ishida, Munehisa Shimamura, et al.. (2006). Prevention of onset of Parkinson’s disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson’s disease. Gene Therapy. 13(23). 1639–1644. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026